OncoPep Revenue and Competitors

Location

$28.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OncoPep's estimated annual revenue is currently $1M per year.(i)
  • OncoPep's estimated revenue per employee is $77,500
  • OncoPep's total funding is $28.4M.

Employee Data

  • OncoPep has 13 Employees.(i)
  • OncoPep grew their employee count by 8% last year.

OncoPep's People

NameTitleEmail/Phone
1
Co-founder & CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Strategy Officer (CSO)Reveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Co-ChairReveal Email/Phone
6
Senior Scientist Immunology and OncologyReveal Email/Phone
7
ControllerReveal Email/Phone
8
Senior Scientist Immunology and OncologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is OncoPep?

Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.

keywords:N/A

$28.4M

Total Funding

13

Number of Employees

$1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M13-19%$3M
#2
$2.1M13N/AN/A
#3
$0.4M13-7%$71.8M
#4
$1.3M13-46%$96.5M
#5
$1M13-50%$200M